Sirikachorn Tangkawattana Selected Research

Infections

1/2024	Mixed Eimeria and Cryptosporidium infection and its effects on pathology and clinical outcomes in juvenile Asian seabass (Lates calcarifer) cultured in Thailand.
11/2023	Roaming behavior of the owned domestic cats (Felis catus) with possible roles in the transmission of Opisthorchis viverrini in the endemic area in Khon Kaen, Thailand.
1/2023	Elevated circulating TLR4+ monocytes in patients with liver fluke Opisthorchis viverrini is associated with advanced periductal fibrosis.
1/2022	Immunolocalization and functional analysis of Opisthorchis viverrini-M60-like-1 metallopeptidase in animal models.
1/2022	Knockout of liver fluke granulin, Ov-grn-1, impedes malignant transformation during chronic infection with Opisthorchis viverrini.
5/2021	Investigation of possible alternate animal reservoir hosts of Opisthorchis viverrini.
8/2017	Efficacious and safe dose of praziquantel for the successful treatment of feline reservoir hosts with opisthorchiasis.
8/2017	Decreased risk of cholangiocarcinogenesis following repeated cycles of Opisthorchis viverrini infection-praziquantel treatment: Magnetic Resonance Imaging (MRI) and histopathological study in a hamster model.
11/2016	Differential Protein Expression in the Hemolymph of Bithynia siamensis goniomphalos Infected with Opisthorchis viverrini.
11/2016	PREVLENCE AND RISK FACTORS FOR OPISTHORCHIS VIVERRINI INFECTION AMONG CATS AND DOGS IN SIX DISTRICTS SURROUNDING THE UBOLRATANA DAM, AN ENDEMIC AREA FOR HUMAN OPISTHORCHIASIS IN NORTHEASTERN THAILAND.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sirikachorn Tangkawattana Research Topics

Disease

10	Infections 01/2024 - 11/2016
8	Opisthorchiasis 01/2022 - 03/2012
3	Neoplasms (Cancer) 01/2022 - 01/2019
2	Veterinary Venereal Tumors (Transmissible Venereal Tumor) 01/2019 - 01/2019
2	Residual Neoplasm 01/2018 - 08/2016
1	Wounds and Injuries (Trauma) 01/2024
1	Inflammation (Inflammations) 11/2023
1	Persistent Infection 01/2022
1	Coinfection 01/2018
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Eosinophilia 08/2017
1	Cholangiocarcinoma 08/2017
1	Lymphoma (Lymphomas) 01/2016

Drug/Important Bio-Agent (IBA)

5	Formaldehyde (Formol)FDA Link 11/2023 - 03/2012
4	Ether (Diethyl Ether)IBA 11/2023 - 03/2012
2	Reactive Nitrogen SpeciesIBA 01/2024 - 11/2023
2	Free RadicalsIBA 11/2023 - 01/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2023 - 01/2023
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2016
2	AntigensIBA 01/2018 - 01/2018
2	Antigen Receptors (Antigen Receptor)IBA 01/2018 - 01/2016
2	Praziquantel (Biltricide)FDA Link 08/2017 - 08/2017
2	Cathepsin FIBA 08/2017 - 12/2015
2	IgYIBA 08/2017 - 12/2015
1	18S Ribosomal RNAIBA 01/2024
1	DNA (Deoxyribonucleic Acid)IBA 11/2023
1	CytokinesIBA 01/2023
1	GranulinsIBA 01/2022
1	NitrosaminesIBA 01/2022
1	EnzymesIBA 01/2022
1	hyaluronate lyase (spreading factor)IBA 01/2022
1	InterferonsIBA 01/2019
1	CollagenIBA 01/2019
1	Asparaginase (Elspar)FDA Link 01/2019
1	Antiviral Agents (Antivirals)IBA 01/2019
1	Vincristine (Oncovin)FDA LinkGeneric 01/2019
1	Alanine Transaminase (SGPT)IBA 08/2017
1	ethyl acetateIBA 08/2017
1	Cysteine Proteases (Cysteine Protease)IBA 12/2015

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2019 - 08/2016
1	Immunotherapy 01/2019
1	CHOP protocol (VDCP protocol) 01/2018